BRD4 was identified as promising target structure in acute myeloid leukemia as inhibition of BRD4 using shRNA or a small molecule inhibitor resulted in anti-leukemic effects in vitro as well as in vivo [12]. This evidence concerns the gene BRD4 and acute myeloid leukemia.